<DOC>
	<DOCNO>NCT01089985</DOCNO>
	<brief_summary>The purpose study examine efficacy safety autologous serum eye drop people recalcitrant dry eye .</brief_summary>
	<brief_title>Use Autologous Serum Eye-drops Tears Patients With Recalcitrant Dry Eye</brief_title>
	<detailed_description>A group select dry eye patient Singapore National Eye Centre exhaust usual treatment option ( lubricant , topical immunosuppressive punctal occlusion ) keen tarsorrhaphy recruit . After informed consent , undergo plasmapheresis start daily autologous serum eyedrop period 4 month . Clinical monitor standard dry eye parameter punctate corneal keratitis , Schirmers test , tear break time well severity frequency dry eye symptom conduct . Tear inflammatory protein capture Schirmers paper pre post treatment analyse well .</detailed_description>
	<mesh_term>Xerophthalmia</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Seen dry eye service Singapore National Eye Centre Age 21 75 year old Symptomatic dry eye VA worse 6/12 Snellen chart Presence corneal punctate stain involve central zone Exhausted consider standard therapy therapy acceptable patient physician No contraindication blood extraction/plasmapheresis HIV/HCV/HBV/syphilis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>